429 related articles for article (PubMed ID: 27006759)
1. Metals and Neurodegeneration.
Chen P; Miah MR; Aschner M
F1000Res; 2016; 5():. PubMed ID: 27006759
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial metals as a potential therapeutic target in neurodegeneration.
Grubman A; White AR; Liddell JR
Br J Pharmacol; 2014 Apr; 171(8):2159-73. PubMed ID: 24206195
[TBL] [Abstract][Full Text] [Related]
5. The aging brain: impact of heavy metal neurotoxicity.
Ijomone OM; Ifenatuoha CW; Aluko OM; Ijomone OK; Aschner M
Crit Rev Toxicol; 2020 Oct; 50(9):801-814. PubMed ID: 33210961
[TBL] [Abstract][Full Text] [Related]
6. Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models.
Woo J; Cho H; Seol Y; Kim SH; Park C; Yousefian-Jazi A; Hyeon SJ; Lee J; Ryu H
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33546471
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases.
Wei R; Wei P; Yuan H; Yi X; Aschner M; Jiang YM; Li SJ
Biol Trace Elem Res; 2024 Jan; ():. PubMed ID: 38206494
[TBL] [Abstract][Full Text] [Related]
8. Metals and free radicals in neurodegeneration.
Olanow CW; Arendash GW
Curr Opin Neurol; 1994 Dec; 7(6):548-58. PubMed ID: 7866588
[TBL] [Abstract][Full Text] [Related]
9. Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders.
Singh S; Ahuja A; Pathak S
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243956
[TBL] [Abstract][Full Text] [Related]
10. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
Davies KM; Mercer JF; Chen N; Double KL
Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
Liddell JR
Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
[TBL] [Abstract][Full Text] [Related]
12. Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.
Li Y; Jiao Q; Xu H; Du X; Shi L; Jia F; Jiang H
Front Mol Neurosci; 2017; 10():339. PubMed ID: 29114205
[TBL] [Abstract][Full Text] [Related]
13. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
14. Emerging Evidence of Golgi Stress Signaling for Neuropathies.
Shirai R; Yamauchi J
Neurol Int; 2024 Mar; 16(2):334-348. PubMed ID: 38525704
[TBL] [Abstract][Full Text] [Related]
15. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.
Calabrese V; Guagliano E; Sapienza M; Panebianco M; Calafato S; Puleo E; Pennisi G; Mancuso C; Butterfield DA; Stella AG
Neurochem Res; 2007; 32(4-5):757-73. PubMed ID: 17191135
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and neurodegeneration: the involvement of iron.
Carocci A; Catalano A; Sinicropi MS; Genchi G
Biometals; 2018 Oct; 31(5):715-735. PubMed ID: 30014355
[TBL] [Abstract][Full Text] [Related]
17. Exposure of metal toxicity in Alzheimer's disease: An extensive review.
Islam F; Shohag S; Akhter S; Islam MR; Sultana S; Mitra S; Chandran D; Khandaker MU; Ashraf GM; Idris AM; Emran TB; Cavalu S
Front Pharmacol; 2022; 13():903099. PubMed ID: 36105221
[TBL] [Abstract][Full Text] [Related]
18. Reviewing Biochemical Implications of Normal and Mutated Huntingtin in Huntington's Disease.
Tellone E; Galtieri A; Ficarra S
Curr Med Chem; 2020; 27(31):5137-5158. PubMed ID: 31223078
[TBL] [Abstract][Full Text] [Related]
19. Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.
Sanchez-Barcelo EJ; Rueda N; Mediavilla MD; Martinez-Cue C; Reiter RJ
Curr Med Chem; 2017 Nov; 24(35):3851-3878. PubMed ID: 28721826
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
Gao J; Wang L; Liu J; Xie F; Su B; Wang X
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
